i2E

Bab provides convenience in the online shopping experience through a universal shopping cart that allows users to add different items from different stores, all in one place, in a Big Ass Bag. Bab allows those making purchasing decisions to compare products, curate a collection, and save and share selections when shopping online.

THG Energy Solutions, LLC specializes in providing energy management solutions through a comprehensive web-based platform. The company offers a range of services, including energy analytics, sustainability reporting, automated demand response, and load management, aimed at helping clients optimize their energy usage and reduce costs. With capabilities in data collection, verification, and accounts payable integration, THG serves a diverse clientele, including governments, healthcare facilities, educational institutions, multi-location retailers, and various commercial entities. Founded in 2003 and headquartered in Austin, Texas, with additional offices in Tulsa and Atlanta, THG Energy Solutions leverages its team's expertise in energy marketing, building controls, engineering, and data management to deliver tailored solutions that prioritize clients' interests. The company has formed a strategic alliance with Energy Hippo, Inc. to enhance its service offerings.

Simergent, LLC is a company that manufactures automated peritoneal dialysis devices aimed at providing affordable home dialysis solutions for both developed and emerging markets. Founded in 2014, the company is headquartered in Oklahoma City, Oklahoma, with additional operations in Chicago, Illinois. Simergent's devices are designed to be cost-effective and user-friendly, featuring a disposable tubing set that operates independently to troubleshoot issues. This innovation allows patients to maintain a normal lifestyle and socialize with family and friends while undergoing treatment at home.

BPEndo, LLC is a medical device company based in Norman, Oklahoma, founded in 2016. The company specializes in developing an insufflation retention device designed to address the problem of a deflating colon during colonoscopies. This innovative device creates an airtight seal in the rectum, which helps prevent air or fluid incontinence. By maintaining proper insufflation, the device allows physicians to maneuver the endoscope with greater freedom, ultimately enhancing the safety and efficiency of colonoscopic procedures.

Progentec Diagnostics, Inc. is focused on developing advanced diagnostic tests aimed at improving the management of systemic lupus erythematosus (SLE). The company's flagship platform, aiSLE DX, offers tools such as a flare prediction score, which proactively measures disease activity, and an early diagnosis test for lupus. Established in 2015 and headquartered in Oklahoma City, Oklahoma, Progentec collaborates with various research institutions and experts globally to leverage innovations in diagnostics. The company is dedicated to addressing significant unmet needs in healthcare by enhancing disease management through improved diagnostic capabilities, ultimately aiming to facilitate early detection and reduce disease incidence.

Whiteboard CRM is a specialized customer relationship management software designed for mortgage professionals, developed by experienced industry producers. Recognized for its innovation, the platform helps loan officers and branch managers enhance their business by fostering relationships with clients and referral partners. The software streamlines lead management, partner interactions, and team productivity, allowing lenders to implement effective business strategies across their organizations. It supports sales, marketing, and follow-up campaigns while ensuring compliance, enabling mortgage businesses to close more loans and boost referrals. By automating communication through pre-loaded content and phone scripts, Whiteboard CRM empowers users to maintain consistent engagement with clients and partners, ultimately driving revenue growth.

SendaRide, Inc. is a company based in Oklahoma City, Oklahoma, that specializes in providing non-emergency medical transportation services. Founded in 2016, SendaRide operates a platform tailored for the healthcare industry, enabling users to book both on-demand and pre-scheduled transportation. The application offers customized transport solutions for non-emergency medical patients, the elderly, and children, allowing users to find suitable transportation options easily. Additionally, the platform includes features such as GPS monitoring, live video feeds during transportation, and the ability to rate drivers or caretakers based on the services received. This comprehensive approach ensures that patients can reach their destinations safely and reliably.

Raw Space For Rent is an online community marketplace that connects people looking to rent out their unused space with people looking for spaces to rent: artists, musicians, fashion shows, weddings, events, readings, car storage, pop-up shops, filmmakers, performance art, roller skating, meditation circles, workspace, cocktail parties or where ever your imagination takes you.

iRecommend Software™ develops intelligent business solutions utilizing artificial intelligence (AI), machine learning, and dynamic data modeling. In a consumer-driven economy, businesses across all industries, are facing the challenge to remain relevant and provide highly personalized products and services. iRecommend's leading solution, Recommendation360™ is a recommendation engine with applications across multiple industries, including recruiting, real estate, retail/e-commerce, entertainment, travel, government, and healthcare. These industry-specific solutions enable businesses to generate hyper-personalized recommendations of products and services for their customers. Recommendation360's proprietary technology rapidly aggregates and analyzes millions of data points from the public domain to provide the right products or services to the right person at the right time. Headquartered in Tulsa, Oklahoma with offices in Oklahoma City, New York, San Francisco, London, and Dubai.

Clear River Enviro is a U.S.-based company that manufactures and markets devices, which allow hospitals and nursing homes to dispose of their pharmaceutical waste safely and conveniently. The company was founded in 2009 and is based in Sugar Land, Texas.

Linear Health Sciences is a medical device company focused on developing innovative products for medical tubing, utilizing its proprietary breakaway safety-valve technology. This technology aims to prevent unwanted disconnection of medical tubing, thereby enhancing the healthcare experience for patients, caregivers, and healthcare facilities. The company has made significant strides in securing global patent protections and obtaining FDA clearance for its flagship product, the Orchid Safety Release Valve. With a total addressable market exceeding $1 billion annually, Linear Health Sciences was founded by a physician and two engineers, emphasizing a strong blend of medical and engineering expertise in its product development efforts.

Progentec Diagnostics, Inc. is focused on developing advanced diagnostic tests aimed at improving the management of systemic lupus erythematosus (SLE). The company's flagship platform, aiSLE DX, offers tools such as a flare prediction score, which proactively measures disease activity, and an early diagnosis test for lupus. Established in 2015 and headquartered in Oklahoma City, Oklahoma, Progentec collaborates with various research institutions and experts globally to leverage innovations in diagnostics. The company is dedicated to addressing significant unmet needs in healthcare by enhancing disease management through improved diagnostic capabilities, ultimately aiming to facilitate early detection and reduce disease incidence.

Happily is a developer of a date-planning application designed to help couples rediscover and enhance their date nights. The app offers personalized date ideas, gifting suggestions, and monthly subscription boxes tailored for couples, ensuring users can enjoy a unique experience each month. By facilitating activities that encourage quality time together, Happily aims to foster deeper connections and meaningful moments in relationships. Through its user-friendly platform, couples can conveniently access a variety of engaging options to enrich their time spent together.

Happily is a developer of a date-planning application designed to help couples rediscover and enhance their date nights. The app offers personalized date ideas, gifting suggestions, and monthly subscription boxes tailored for couples, ensuring users can enjoy a unique experience each month. By facilitating activities that encourage quality time together, Happily aims to foster deeper connections and meaningful moments in relationships. Through its user-friendly platform, couples can conveniently access a variety of engaging options to enrich their time spent together.

WeGoLook is mobile technology company featuring a crowdsourced platform of 30,000+ "Lookers"​ nationwide to complete on-demand field services, including inspections and custom tasking. Our agents, known as "Lookers"​, collect field data, photos, and video via the WeGoLook mobile app and/or complete custom tasking, such as item pickup, delivery, document research and more. WeGoLook specializes in verifying autos, properties, boats, heavy equipment, antiques, electronics, furniture, RV’s and other assets. WeGoLook has expanded to international markets, including the United Kingdom, Canada, and Australia with other countries soon to follow. How it works: Companies or individuals engage with WeGoLook to order an on-site inspection report or custom task via WeGoLook’s web platform for autos, real estate, heavy equipment, courier services, notary services, and more. WeGoLook then dispatches an Agent within proximity of the location to complete the on-site inspection by collecting dynamic data, photos, and video utilizing the WeGoLook Mobile Application for iOS or Android. The report goes through quality assurance review and delivered to an insurance provider in their preferred format (API, .html, PDF, compressed images, and more).

Moleculera Labs was founded by Drs. Craig Shimasaki and Madeleine Cunningham in 2011, to medically understand and clinically identify the underlying biological root of neurological, psychiatric, and behavioral disorders. Similar to the emergence of the immuno-oncology connection, epidemiological and research evidence demonstrates that a large portion of neuropsychiatric disorders are caused by an autoimmune dysfunction. The Company owns and operates a fully accredited clinical laboratory with its first revenue generating product—a blood panel called the Cunningham Panel™ that detects brain and nervous system targeted autoimmune antibodies in patients with neurologic, psychiatric, and behavioral disorders triggered by an infection. Patients are diagnosed with PANS, PANDAS, autism spectrum disorder, ADD/ADHD, bipolar disorder, anxiety disorder, Tourette’s, obsessive compulsive disorder (OCD), schizophrenia, or other neurologic and psychiatric syndromes, whereas the root may be a dysfunctional immune response. Symptoms include OCD, anxiety, depression, psychosis, motor or vocal tics, verbal and non-verbal communication difficulty, deteriorating social skills, eating disorders, academic regression, and rage. These patients are typically prescribed neuropsychiatric drugs, often resulting in little or no improvement. However, once a patient is correctly diagnosed through testing, treatment is redirected towards the immune system, neuroinflammation, and subclinical infections, resulting in remarkable recoveries, sometimes after decades of suffering. Moleculera is the sole clinical laboratory performing this panel covered by two U.S. patents. The Company has received and processed over 13,000 blood specimens ordered by over 1,700 physicians in over 50 countries, all prior to launching a sales force. The Company generated $1.1 MM in 2021 and is preparing to scale for revenue expansion with expectations of revenue ~$25 MM in 4-5 years. The company is now applying this technology to autoimmune cardiovascular disease and Long-COVID symptoms. The basic research that led to the identification of these antineuronal antibody targets was studied for over 20 years in the laboratory of Dr. Madeleine Cunningham at The University of Oklahoma Health Sciences Center, with subsequent collaboration from the Pediatric Branch of the National Institutes of Mental Health (NIMH). Scientific and clinical results have been published in multiple top-tier peer-reviewed journals. Certain infections that have been found to trigger these autoimmune antibodies include strep, Lyme, mycoplasma, Babesia, bartonella, coxsackie virus, and others. Medical journals have reported an autoimmune response to SARS-CoV-2 (COVID-19), with approximately one-third of patients experiencing some neurologic or psychiatric symptoms. The patented Cunningham Panel™ consists of five tests. Four which measure levels of autoantibodies directed against Dopamine D1 receptor, Dopamine D2L receptor, Lysoganglioside GM1, and Tubulin. A fifth test measures CaM Kinase II activation, a key enzyme involved in the production of neurotransmitters dopamine, epinephrine, and norepinephrine. Autoimmune antibodies that bind to these targets interfere with or block normal neurologic activity in the brain and nervous system. The laboratory results assist a physician in making a diagnosis and identifying the appropriate therapy. In addition to individual clinicians who order the panel, the Company has provided testing to over 80 medical institution customers. In a 2020 publication in the Journal of Neuroimmunology, the Cunningham Panel demonstrated an 88% sensitivity and 92% specificity with an accuracy of 90% correlating these autoantibody elevations and neuropsychiatric symptoms before and after treatment. The Cunningham Panel aids a clinician’s treatment decision by directing them to the underlying subclinical infections and neuroimmune dysfunction, rather than simply treating symptoms. Effective treatments typically include various anti-infectives, anti-inflammatory agents and immunomodulators. Moleculera' s Test Panel generates an average realized revenue of $900 through existing CPT codes and patient billing. The Company has generated over $10 million in cumulative revenue since opening. During the COVID-19 pandemic, revenues for 2021 were $1.1 million, all prior to adding a sales force. Approximately 10% of orders come from a growing international market, with the Company receiving orders from over 1,700 clinicians. Moleculera Labs has one of the largest IRB approved and clinically annotated serum specimen biobanks of over 13,000 specimens utilized for research and development of new products for autoimmune neuropsychiatric disorders. The Company has demonstrated its panel’s clinical utility in multiple neuropsychiatric disorders and have been able to predict treatment efficacy while working with pharmaceutical and research partners to assist in identifying novel drug targets. There is a clear unmet medical need and demand in this $23 billion dollar neuropsychiatric and behavioral disorder market. Moleculera recently in-licensed exclusive technology for multiple autoimmune antibody targets against the heart, which are implicated in a portion of multiple cardiovascular diseases such as heart failure, cardiomyopathy, atrial fibrillation, and myocarditis. With this technology along with proposed clinical studies and validation in process, the Company expects to develop and commercialize two additional panels. One panel will target various cardiovascular diseases (world-wide market of $4.9 trillion) infection-triggered autoimmunity, and another panel for diagnosing and treatment-monitoring of Long-COVID (estimated at $6.5 trillion). Our precision medicine business model is fashioned after Foundation Medicine and Genomic Health, whose precision medicine companies were acquired by Roche in 2018 for $5.3 billion, and Exact Sciences in 2019 for $2.8 billion, respectively. Moleculera Labs is led by Dr. Craig Shimasaki, a serial entrepreneur with over 35 years of biotechnology experience, who began his career at Genentech. He co-founded multiple companies, participated in taking several companies public into the U.S. and the Canadian stock exchange, led five products through the FDA diagnostic approval process, and has directed two CLIA labs, raising over $30 million for these companies. Dr. Madeleine Cunningham, Chief Scientific Officer, is an internationally recognized leader in infection-induced autoimmune neuropsychiatric disorders and is a tenured professor at the University of Oklahoma with over 40 years of research and over 130 authored publications in leading scientific and medical journals. Dr. James Appleman is VP of R&D and Clinical Development and has 30+ years’ experience in building successful diagnostic and therapeutic companies from inception through successful exits, including a $230M exit to Roche. Mr. Fred Hiller is CFO and brings 45+ years’ experience in corporate finance and accounting. He began his career at Touche Ross & Co. in 1962, serving as controller at Elgin National and Columbia Pictures, and CFO at Wilkinson Sword. He has been a financial consultant to numerous companies including two biotechnology companies and one that was publicly traded.

WeGoLook is mobile technology company featuring a crowdsourced platform of 30,000+ "Lookers"​ nationwide to complete on-demand field services, including inspections and custom tasking. Our agents, known as "Lookers"​, collect field data, photos, and video via the WeGoLook mobile app and/or complete custom tasking, such as item pickup, delivery, document research and more. WeGoLook specializes in verifying autos, properties, boats, heavy equipment, antiques, electronics, furniture, RV’s and other assets. WeGoLook has expanded to international markets, including the United Kingdom, Canada, and Australia with other countries soon to follow. How it works: Companies or individuals engage with WeGoLook to order an on-site inspection report or custom task via WeGoLook’s web platform for autos, real estate, heavy equipment, courier services, notary services, and more. WeGoLook then dispatches an Agent within proximity of the location to complete the on-site inspection by collecting dynamic data, photos, and video utilizing the WeGoLook Mobile Application for iOS or Android. The report goes through quality assurance review and delivered to an insurance provider in their preferred format (API, .html, PDF, compressed images, and more).

Synereca Pharmaceuticals, Inc. is a research-stage biopharmaceutical company focused on developing orally active drugs that enhance the effectiveness of existing antibiotics. Founded in 2009 and headquartered in Chapel Hill, North Carolina, with additional laboratories in Oklahoma City, the company specializes in compounds that improve the activity of Colistin against gram-negative bacteria while minimizing toxicity. Its portfolio includes prototypic RecA inhibitors targeting various pathogenic bacteria, such as E. coli, which are responsible for critical infections, including those of the lungs, urinary tract, and skin. Synereca's platform identifies multiple chemical subclasses of compounds designed to potentiate current classes of antibiotics, including polymyxins, carbapenems, aminoglycosides, and fluoroquinolones, thereby providing drug manufacturers with effective solutions for bacterial infections.

Well Checked Systems International, LLC, operating as WellChecked, specializes in remote monitoring solutions for oil and gas well sites. Founded in 2012 and based in Tulsa, Oklahoma, the company provides a comprehensive platform that includes video monitoring, reporting, alerting, and data storage. Its services are designed to assist pumpers, owners, and operators by enabling them to monitor well site activity from a distance. Key features include motion sensing, gate activity monitoring, tank level change alerts, and cloud-based video surveillance for easy retrieval. The platform aims to enhance safety and security while minimizing the costs and personnel required for on-site monitoring, thereby helping to prevent equipment damage and loss.

Monscierge is an international software company specializing in innovative hospitality solutions. Since 2009, our global team has been developing a system called Connect to facilitate elegant connections between the guest, hotel properties and their brands. Connect solutions encompass modern platforms such as mobile, tablet, large-format touchscreen devices and a central web-based platform to manage all content. We have also developed custom solutions to address specific needs. With installations around the world, Monscierge is dedicated to improving guest experiences and hotel staff efficiency around the world by facilitating an experience that will inspire customer loyalty.

Otologic Pharmaceutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for hearing disorders. Established in 2009 and located in Oklahoma City, the company is dedicated to addressing acute hearing loss, particularly through its lead product, HPN1010, an oral medication designed to treat acute noise-induced hearing loss. Otologic aims to prevent the progression to permanent hearing impairment and has plans to extend the applications of HPN1010 to other forms of hearing loss, including those caused by chemotherapy drugs like Cisplatin. Additionally, the company's research encompasses a range of therapeutic approaches, including programs for cochlear implant-related hearing loss and conditions such as Meniere's disease and tinnitus. By advancing these novel pharmacological solutions, Otologic Pharmaceutics seeks to improve the quality of life for individuals suffering from hearing impairment.

SmartPanel is developing an innovative new home energy management product to be mounted on the circuit breaker of homes and small commercial buildings. Whereas competing technologies focus on controlling power at switches and plugs, Smart Panel takes a holistic view of the home and controls energy distribution at the natural energy hub. By placing a single device at the breaker, the homeowner achieves control with a single affordable device.

Miira Artist Tools is a versatile tool designed for the professional artists, designers, and beginners.

EQUIP Advantage provides immediate access to the oil and gas industry’s equipment at the right time.

SIVI's core product is LaunchLeader, the micro-crowdfunding platform for entrepreneurs to rally supporters and raise startup money for their prototypes (MVPs). The unique fundraising design is set up like a wedding registry wish list so donors can back specific startup tools, e.g. video, logo, social media ads. LaunchLeader is positioned as a pre-Kickstarter/Indiegogo or pre-accelerator crowdfunding platform when friends and family are your main supporters. LaunchLeader's parent company, SIVI, is a virtual incubator started by successful founders dedicated to democratizing entrepreneurship.

Tailwind is a prominent marketing platform tailored for small businesses, entrepreneurs, creators, and marketers. It provides tools that facilitate the planning, creation, execution, and optimization of marketing campaigns across various digital platforms, including email, Facebook, Instagram, and Pinterest. By integrating multiple standalone marketing tools into a unified system, Tailwind aims to empower small businesses to become effective omni-channel marketers, catering to their specific needs. Additionally, Tailwind offers a utility-first CSS framework designed to simplify content marketing, enabling users to enhance their marketing efforts and connect with a broader audience. Through its comprehensive suite of services, Tailwind is reshaping the marketing landscape for small businesses.

Moleculera Labs was founded by Drs. Craig Shimasaki and Madeleine Cunningham in 2011, to medically understand and clinically identify the underlying biological root of neurological, psychiatric, and behavioral disorders. Similar to the emergence of the immuno-oncology connection, epidemiological and research evidence demonstrates that a large portion of neuropsychiatric disorders are caused by an autoimmune dysfunction. The Company owns and operates a fully accredited clinical laboratory with its first revenue generating product—a blood panel called the Cunningham Panel™ that detects brain and nervous system targeted autoimmune antibodies in patients with neurologic, psychiatric, and behavioral disorders triggered by an infection. Patients are diagnosed with PANS, PANDAS, autism spectrum disorder, ADD/ADHD, bipolar disorder, anxiety disorder, Tourette’s, obsessive compulsive disorder (OCD), schizophrenia, or other neurologic and psychiatric syndromes, whereas the root may be a dysfunctional immune response. Symptoms include OCD, anxiety, depression, psychosis, motor or vocal tics, verbal and non-verbal communication difficulty, deteriorating social skills, eating disorders, academic regression, and rage. These patients are typically prescribed neuropsychiatric drugs, often resulting in little or no improvement. However, once a patient is correctly diagnosed through testing, treatment is redirected towards the immune system, neuroinflammation, and subclinical infections, resulting in remarkable recoveries, sometimes after decades of suffering. Moleculera is the sole clinical laboratory performing this panel covered by two U.S. patents. The Company has received and processed over 13,000 blood specimens ordered by over 1,700 physicians in over 50 countries, all prior to launching a sales force. The Company generated $1.1 MM in 2021 and is preparing to scale for revenue expansion with expectations of revenue ~$25 MM in 4-5 years. The company is now applying this technology to autoimmune cardiovascular disease and Long-COVID symptoms. The basic research that led to the identification of these antineuronal antibody targets was studied for over 20 years in the laboratory of Dr. Madeleine Cunningham at The University of Oklahoma Health Sciences Center, with subsequent collaboration from the Pediatric Branch of the National Institutes of Mental Health (NIMH). Scientific and clinical results have been published in multiple top-tier peer-reviewed journals. Certain infections that have been found to trigger these autoimmune antibodies include strep, Lyme, mycoplasma, Babesia, bartonella, coxsackie virus, and others. Medical journals have reported an autoimmune response to SARS-CoV-2 (COVID-19), with approximately one-third of patients experiencing some neurologic or psychiatric symptoms. The patented Cunningham Panel™ consists of five tests. Four which measure levels of autoantibodies directed against Dopamine D1 receptor, Dopamine D2L receptor, Lysoganglioside GM1, and Tubulin. A fifth test measures CaM Kinase II activation, a key enzyme involved in the production of neurotransmitters dopamine, epinephrine, and norepinephrine. Autoimmune antibodies that bind to these targets interfere with or block normal neurologic activity in the brain and nervous system. The laboratory results assist a physician in making a diagnosis and identifying the appropriate therapy. In addition to individual clinicians who order the panel, the Company has provided testing to over 80 medical institution customers. In a 2020 publication in the Journal of Neuroimmunology, the Cunningham Panel demonstrated an 88% sensitivity and 92% specificity with an accuracy of 90% correlating these autoantibody elevations and neuropsychiatric symptoms before and after treatment. The Cunningham Panel aids a clinician’s treatment decision by directing them to the underlying subclinical infections and neuroimmune dysfunction, rather than simply treating symptoms. Effective treatments typically include various anti-infectives, anti-inflammatory agents and immunomodulators. Moleculera' s Test Panel generates an average realized revenue of $900 through existing CPT codes and patient billing. The Company has generated over $10 million in cumulative revenue since opening. During the COVID-19 pandemic, revenues for 2021 were $1.1 million, all prior to adding a sales force. Approximately 10% of orders come from a growing international market, with the Company receiving orders from over 1,700 clinicians. Moleculera Labs has one of the largest IRB approved and clinically annotated serum specimen biobanks of over 13,000 specimens utilized for research and development of new products for autoimmune neuropsychiatric disorders. The Company has demonstrated its panel’s clinical utility in multiple neuropsychiatric disorders and have been able to predict treatment efficacy while working with pharmaceutical and research partners to assist in identifying novel drug targets. There is a clear unmet medical need and demand in this $23 billion dollar neuropsychiatric and behavioral disorder market. Moleculera recently in-licensed exclusive technology for multiple autoimmune antibody targets against the heart, which are implicated in a portion of multiple cardiovascular diseases such as heart failure, cardiomyopathy, atrial fibrillation, and myocarditis. With this technology along with proposed clinical studies and validation in process, the Company expects to develop and commercialize two additional panels. One panel will target various cardiovascular diseases (world-wide market of $4.9 trillion) infection-triggered autoimmunity, and another panel for diagnosing and treatment-monitoring of Long-COVID (estimated at $6.5 trillion). Our precision medicine business model is fashioned after Foundation Medicine and Genomic Health, whose precision medicine companies were acquired by Roche in 2018 for $5.3 billion, and Exact Sciences in 2019 for $2.8 billion, respectively. Moleculera Labs is led by Dr. Craig Shimasaki, a serial entrepreneur with over 35 years of biotechnology experience, who began his career at Genentech. He co-founded multiple companies, participated in taking several companies public into the U.S. and the Canadian stock exchange, led five products through the FDA diagnostic approval process, and has directed two CLIA labs, raising over $30 million for these companies. Dr. Madeleine Cunningham, Chief Scientific Officer, is an internationally recognized leader in infection-induced autoimmune neuropsychiatric disorders and is a tenured professor at the University of Oklahoma with over 40 years of research and over 130 authored publications in leading scientific and medical journals. Dr. James Appleman is VP of R&D and Clinical Development and has 30+ years’ experience in building successful diagnostic and therapeutic companies from inception through successful exits, including a $230M exit to Roche. Mr. Fred Hiller is CFO and brings 45+ years’ experience in corporate finance and accounting. He began his career at Touche Ross & Co. in 1962, serving as controller at Elgin National and Columbia Pictures, and CFO at Wilkinson Sword. He has been a financial consultant to numerous companies including two biotechnology companies and one that was publicly traded.

Codesy operates an open-source marketplace designed to connect software developers with valuable software bugs. This platform allows coders to engage in a pay-what-you-want system, providing flexibility in how they set their fees and payments. By facilitating transactions between developers of open-source software and potential buyers, Codesy simplifies the process for programmers looking to offer their services. Users can easily connect with each other, fostering a collaborative environment for app and website development.

Offerboxx is a location based marketing software that makes it possible for businesses to collect rich information from consumers on-site and in an engaging way. Offerboxx makes that data available instantly and in a way that measures the results of each campaign.

Synercon Technologies, LLC specializes in developing advanced technology solutions for extracting crash data from the engine control modules of heavy vehicles, including trucks and buses. The company offers a range of products, such as the Forensic Link Adapter (FLA), which downloads data from heavy vehicles, and the Smart Sensor Simulator, which allows investigators to emulate vehicle functions for bench downloads without generating extraneous fault codes. Additionally, Synercon provides TruckCRYPT, a software solution that encrypts and presents the data extracted from the FLA. Beyond its hardware and software offerings, the company delivers services in chip-level digital forensics, heavy vehicle data extraction, crash reconstruction, expert testimony, electronics design, embedded Linux implementations, and vehicle networking. Founded in 2013 and headquartered in Tulsa, Oklahoma, Synercon Technologies aims to enhance forensic investigations by ensuring the integrity of vital vehicle data post-accident.

Drik is an Oklahoma City-based provider of toxicology services for companies developing new drugs. Led by Kumar Sripathirathan, founder and CEO, Drik provides customized testing which help researchers and pharmaceutical companies identify toxicology requirements and the safety of new drugs under development.

Sway Medical, LLC, founded in 2011 and based in Aledo, Texas, develops FDA-cleared mobile applications designed to monitor patient outcomes across various medical fields, including orthopedics, geriatrics, and pharmacology. The company's flagship product, Sway Balance, utilizes advanced motion analysis protocols and algorithms to assess balance and detect instability, particularly following head injuries. This mobile software enables healthcare professionals, sports coaches, and other users to conduct objective balance and reaction time testing in diverse environments, providing real-time data for concussion management and overall patient monitoring. By offering quantifiable insights into postural stability, Sway Medical aims to enhance the quality of care in physical therapy, orthopedic practices, senior living facilities, and worksite medical clinics.

ICEdot, a Tulsa, Oklahoma-based developer of a crash sensor attached to the safety helmet of sportsmen. Led by Chris Zenthoefer, CEO, ICEdot has developed a crash sensor attached to the safety helmet of cyclists, skiers, snow boarders, BMX bikers and other action sport participants to detect forces consistent with head injury and notify predesignated health and geolocation information over sms/text.

Your residents practically live on their phones. ReTenant builds you your very own app, so you can build better communication, better service and better community. Over 70% of all apartment properties still use paper fliers to communicate important messages. Communication is what builds relationships — so imagine what kind of relationships these really are. Your app will allow you to replace paper, portals, emails and smoke signals on day one. Residents sound off much more frequently on their phones. Your app makes it super convenient for your residents to communicate problems and make suggestions. You will know what is wrong instantly, coordinate and communicate fixes seamlessly, and take care of problems faster — delighting your residents.

The Campaign Solution optimizes candidates’ time and resources. It was founded by Dan Mazzei in 2010.

EmpowrNet will offer a mobile application that supports consumers, their family members and their friends in their collective effort to manage the array of long term care services and supports required to safely live at home and avoid nursing home care. Nine of ten individuals age 50+ want to age in place - to live at home as independently as possible as long as possible and avoid nursing home placement. For both consumers and family members the primary concern related to supporting aging in place is retaining the control over their lives they had before the need for long term care services entered the picture. EmpolwrNet's communication tool will give consumers and their families the opportunity to retain control of their lives by gives them the tools to successfully manage the challenges of aging in place.

Medefy is a healthcare app founded in 2018 and based in Tulsa, Oklahoma, that facilitates direct communication between employers and their employees regarding health benefits. The platform empowers health plan members by providing personalized guidance throughout their healthcare journey, helping them navigate the complexities of benefits offerings. Medefy enables employees to shop for better-priced, higher-quality healthcare providers in their area, while also offering tools such as telemedicine, narrow networks, and chronic disease management. By fostering engagement and informed decision-making, Medefy aims to improve healthcare outcomes and enhance the overall benefits experience for both employers and employees.

Docvia is a privately held software venture that provides secure, HIPAA-compliant electronic access between established patients and their health providers. The company's software was first commercially deployed at St. John Health System in Tulsa, Oklahoma. The Docvia team is comprised of practicing physicians, software engineers and designers that work together with community leaders in order to provide safe, simple and inexpensive health access around the world.

Expert TA, LLC offers a web-based grading software solution designed for professors and teaching assistants to efficiently grade homework assignments in subjects such as engineering, mathematics, physics, and chemistry. Founded in 2009 and based in Tulsa, Oklahoma, the company provides features like Homework Mode, which allows educators to create assignments and export grade information for integration with other software, and Tutorial Mode, which simulates the guidance a student might receive during tutoring sessions. This technology enables educators to focus more on teaching while the software handles the complex partial-credit grading of homework problems, enhancing both student learning and teaching effectiveness.

Perk Dynamics™, LLC is a software development company dedicated to increasing the efficiency of coffee and espresso drink operations. We are focused on improving the process and quality of brewed beverage order flows to increase profits, ROI, and customer satisfaction in establishments that serve coffee, tea and other machine produced beverages. With the release of AutoPerk the Automated Barista; Casinos, Resorts, Hotels, Hospitals can now enjoy the high profits of an automated coffee shop that delivers consistent quality Barista Quality Beverages 24/7/365.

OMRF is the Oklahoma Medical Research Foundation. We are dedicated to fighting Alzheimer’s, heart disease, lupus, MS, cancer and other devastating illnesses.

Alkami Technology provides cloud-based digital banking solutions for credit unions and banks. Its platform provides financial institutions a complete digital banking solution ready to facilitate both retail and business user onboarding, engagement, and account servicing. It enables clients to enhance the platform with upgrades and can tailor their experience with additional Alkami products as well as third-party solutions. The company was founded in 2009 and is headquartered in Plano, Texas.

Grocio is a grocery data platform with several product lines: - Grocery comparison shopping - Real-time grocery pricing - Coupon matching to grocery list - Mobile tools for shoppers and grocers

Exerbotics, LLC specializes in manufacturing advanced fitness and wellness equipment designed to enhance healthy living and improve quality of life. Established in 2004 and based in Tulsa, Oklahoma, the company provides a range of products for medical rehabilitation, senior living, and research applications. Their equipment includes machines for various muscle groups, such as chest press, shoulder press, squat, and leg extensions, which measure and record force output for analysis and training purposes. Exerbotics' technology not only tracks capability and monitors activity but also delivers detailed reports on biometrics and workout performance, ensuring that users can compare actual work against prescribed regimens.

Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases. They are targeting the underlying disease mechanism for these disorders. Their target is the adhesion of white blood cells to sites of inflammation mediated by the binding of two proteins, P-selectin and PSGL-1. The company is in preclinical development of humanized antibodies to P-selectin and PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic disorders. Unregulated inflammatory processes play a major role in the harmful effects of multiple inflammatory disorders.

mobiManage is a leader in developing Mobile Web Solutions for businesses. mobiManage’s vision is simple: to build the best mobile solutions on the planet and give their clients the tools to engage their visitors, guests and customers. mobiManage is a true adaptive mobile technology company focused on building an open platform that integrates into any existing website, CMS, CRM or database. They ensure their clients have unique and engaging mobile products that integrate into a comprehensive mobile marketing platform; providing businesses with leading, cutting-edge mobile technology and marketing tools for easy and quick integration into marketing campaigns and strategies. mobiManage builds award-winning, engaging mobile solutions that harmonize with existing websites and marketing programs; all compatible with iOS Apple products, all Android platforms, Windows and Blackberry. Having designed over 400 custom mobile websites and applications, mobiManage provides businesses with custom design and easy integration with CRM/CMS systems; all with the freedom and flexibility needed for growing businesses. Utilizing mobiManage’s mobiPlatform clients can deploy, manage and support all mobile products allowing for easy real-time changes. Integrated in the platform are a series of marketing tools including mobile advertising, surveys, GEO location, SMS and more. mobiManage offers integrated responsive server-side website design, kiosk solutions with turnkey interactive solutions utilizing Word Press, Joomla, Microsoft and others. They offer free estimates/proposals.

Lifetone Technology develops and markets lifesaving alarming devices. It offers bedside fire alarms and clocks that protect against residential fires; and a bed shaker, which produces strong and intermittent vibration. The company sells its products online, as well as through dealers to children, heavy sleepers, seniors, and people with hearing loss in the United States. Lifetone Technology was formerly known as InnovAlarm Corporation and changed its name to Lifetone Technology in 2008. The company was founded in 2004 and is based in Oklahoma City, Oklahoma with additional offices in Chicago.